The study was published online in JAMA Neurology on March 31, 2025.

but the 2023 American College of Cardiology/American Heart Association/American College of Clinical Pharmacy/Heart Rhythm Society Guideline for the Management and Diagnosis of Atrial Fibrillation ...

Ruff, MD, MPH, of Brigham and Women's Hospital, discusses new data comparing abelacimab with rivaroxaban in patients with atrial fibrillation ... decision [of] which anticoagulant you prescribe ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Current AF management guidelines have introduced the CARE treatment model to strengthen management ...

Rates of oral anticoagulation (OAC) nonprescription in atrial fibrillation approach 50%. Understanding reasons for OAC nonprescription may reduce gaps in guideline‐recommended care. We aimed to ...

1 The notion that greater infarct size and stroke severity linearly increase the risk of bleeding associated with anticoagulation remains embedded in clinical guidelines ... patients with ischemic ...

In a subgroup of patients with atrial fibrillation, resuming anticoagulant therapy was associated with ... case or case series reports, guidelines, technical notes and book chapters. The review of ...

bham.ac.uk Objective To determine whether patients with paroxysmal atrial fibrillation (AF) are less likely to be ... trends in treatment between 2000 and 2015. UK and European guidelines recommend ...

There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

A study led by researchers at the Duke Clinical Research Institute found that just 46 of atrial fibrillation inpatients received a blood thinner at discharge. Disclaimer: AAAS and EurekAlert!